4.7 Article

Tissue- and cell-type-specific molecular and functional signatures of 16p11.2 reciprocal genomic disorder across mouse brain and human neuronal models

期刊

AMERICAN JOURNAL OF HUMAN GENETICS
卷 109, 期 10, 页码 1789-1813

出版社

CELL PRESS
DOI: 10.1016/j.ajhg.2022.08.012

关键词

-

资金

  1. Simons Foundation Autism Research Initiative [SFARI 328656, 573206, SFARI 308955]
  2. Nancy Lurie Marks Family Foundation
  3. U.S. National Institutes of Health [NS093200, HD096326, MH115957, HD104224, MH123155, GM061354, MH123804]
  4. Autism Speaks
  5. Rubicon Fellowship from the Netherlands Organisation for Scientific Research (NWO)

向作者/读者索取更多资源

Chromosome 16p11.2 reciprocal genomic disorder is associated with intellectual disabilities, ASD, and schizophrenia. This disorder disrupts multiple biological processes and affects gene expression and neuronal ratios, potentially impacting neurodevelopment and cognitive function.
Chromosome 16p11.2 reciprocal genomic disorder, resulting from recurrent copy-number variants (CNVs), involves intellectual disability, autism spectrum disorder (ASD), and schizophrenia, but the responsible mechanisms are not known. To systemically dissect molecular effects, we performed transcriptome profiling of 350 libraries from six tissues (cortex, cerebellum, striatum, liver, brown fat, and white fat) in mouse models harboring CNVs of the syntenic 7qF3 region, as well as cellular, transcriptional, and single-cell analyses in 54 isogenic neural stem cell, induced neuron, and cerebral organoid models of CRISPR-engineered 16p11.2 CNVs. Transcriptomewide differentially expressed genes were largely tissue-, cell-type-, and dosage-specific, although more effects were shared between deletion and duplication and across tissue than expected by chance. The broadest effects were observed in the cerebellum (2,163 differentially expressed genes), and the greatest enrichments were associated with synaptic pathways in mouse cerebellum and human induced neurons. Pathway and co-expression analyses identified energy and RNA metabolism as shared processes and enrichment for ASD-associated, loss-of-function constraint, and fragile X messenger ribonucleoprotein target gene sets. Intriguingly, reciprocal 16p11.2 dosage changes resulted in consistent decrements in neurite and electrophysiological features, and single-cell profiling of organoids showed reciprocal alterations to the proportions of excitatory and inhibitory GABAergic neurons. Changes both in neuronal ratios and in gene expression in our organoid analyses point most directly to calretinin GABAergic inhibitory neurons and the excitatory/ inhibitory balance as targets of disruption that might contribute to changes in neurodevelopmental and cognitive function in 16p11.2 carriers. Collectively, our data indicate the genomic disorder involves disruption of multiple contributing biological processes and that this disruption has relative impacts that are context specific.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据